Perfusion parameters and target values during extracorporeal cardiopulmonary resuscitation: a scoping review protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
30 08 2019
Historique:
entrez: 2 9 2019
pubmed: 2 9 2019
medline: 2 10 2020
Statut: epublish

Résumé

Extracorporeal cardiopulmonary resuscitation (eCPR) is increasingly applied in out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA) patients. Treatment results are promising, but the efficacy and safety of the procedure are still unclear. Currently, there are no recommended target perfusion parameters during eCPR, the lack of which could result in inadequate (re)perfusion. We aim to perform a scoping review to explore the current literature addressing target perfusion parameters, target values, corresponding survival rates and neurologic outcomes in OHCA and IHCA patients treated with eCPR. To identify relevant research, we will conduct searches in the electronic databases MEDLINE, EMBASE, Social Science Citation Index, Social Science Citation Index Expanded and the Cochrane library. We will also check references of relevant articles and perform a cited reference research (forward citation tracking).Two independent reviewers will screen titles and abstracts, check full texts for eligibility and perform data extraction. We will resolve dissent by consensus, moderated by a third reviewer. We will include observational and controlled studies addressing target perfusion parameters and outcomes such as survival rates and neurologic findings in OHCA and IHCA patients treated with eCPR. Data extraction tables will be set up, including study and patients' characteristics, aim of study, details on eCPR including target perfusion parameters and reported outcomes. We will summarise the data using tables and figures (ie, bubble plot) to present the research landscape and to describe potential clusters and/or gaps. An ethical approval is not needed. We intend to publish the scoping review in a peer-reviewed journal and present results on a scientific meeting.

Identifiants

pubmed: 31473622
pii: bmjopen-2019-030562
doi: 10.1136/bmjopen-2019-030562
pmc: PMC6720332
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e030562

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: FB und CB are shareholder of Resuscitec GmbH.

Références

Health Info Libr J. 2009 Jun;26(2):91-108
pubmed: 19490148
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
Can J Cardiol. 2013 Jan;29(1):117-21
pubmed: 22640493
Artif Organs. 2013 Feb;37(2):150-6
pubmed: 23379286
Crit Care Med. 2013 May;41(5):1186-96
pubmed: 23388518
Resuscitation. 2014 Aug;85(8):987-92
pubmed: 24746785
J Am Heart Assoc. 2014 Apr 22;3(2):e000533
pubmed: 24755149
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Circulation. 2015 Nov 3;132(18 Suppl 2):S444-64
pubmed: 26472995
Artif Organs. 2016 Sep;40(9):904-9
pubmed: 26684540
Resuscitation. 2016 Apr;101:12-20
pubmed: 26836946
Resuscitation. 2017 Jan;110:133-140
pubmed: 27865775
Herz. 2017 Feb;42(1):27-44
pubmed: 28127638
Resuscitation. 2017 Jul;116:16-21
pubmed: 28458025
N Engl J Med. 2017 May 4;376(18):1737-1747
pubmed: 28467879
Resuscitation. 2017 Jul;116:39-45
pubmed: 28476474
Chest. 2017 Sep;152(3):639-649
pubmed: 28642106
Artif Organs. 2018 Jan;42(1):15-21
pubmed: 28877346
Can J Cardiol. 2018 Feb;34(2):146-155
pubmed: 29249614
CJEM. 2018 Jul;20(4):507-517
pubmed: 29733006
Ann Thorac Surg. 2019 Jan;107(1):311-321
pubmed: 29959943
Med Klin Intensivmed Notfmed. 2018 Sep;113(6):478-486
pubmed: 29967938

Auteurs

Lars Saemann (L)

Department of Cardiovascular Surgery, University Hospital Freiburg Cardiac Centre Freiburg Bad Krozingen Freiburg Branch, Freiburg, Germany lars.saemann@gmx.de.
Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.

Christine Schmucker (C)

Institute for Evidence in Medicine (for Cochrane Germany Foundation), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Freiburg, Germany.

Lisa Rösner (L)

Department of Cardiovascular Surgery, University Hospital Freiburg Cardiac Centre Freiburg Bad Krozingen Freiburg Branch, Freiburg, Germany.

Friedhelm Beyersdorf (F)

Department of Cardiovascular Surgery, University Hospital Freiburg Cardiac Centre Freiburg Bad Krozingen Freiburg Branch, Freiburg, Germany.

Christoph Benk (C)

Department of Cardiovascular Surgery, University Hospital Freiburg Cardiac Centre Freiburg Bad Krozingen Freiburg Branch, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH